Langer, Robert S.

Autor: Langer, Robert S.
Rok: 1948-
Oblast působnosti:

Biogr./Hist. údaje: Americký profesor biomedicínského inženýrství, vědec, zabývá se výzkumem v oblasti rakovinových onemocnění a regenerativní medicíny. Publikuje v oblasti biotechnologií a tkáňového inženýrství.
Zdroj: Autoritní databáze Národní knihovny ČR

Robert Samuel Langer, Jr. FREng (born August 29, 1948 in Albany, New York) is an American engineer, scientist, entrepreneur, inventor and the David H. Koch Institute Professor at the Massachusetts Institute of Technology. He was formerly the Germeshausen Professor of Chemical and Biomedical Engineering and maintains activity in the Department of Chemical Engineering and the Department of Biological Engineering at MIT. He is also a faculty member of the Harvard-MIT Division of Health Sciences and Technology and the David H. Koch Institute for Integrative Cancer Research. He is a widely recognized and cited researcher in biotechnology, especially in the fields of drug delivery systems and tissue engineering. He has been cited over 169,000 times and has an h-index of 210 as of April 3, 2015. His most cited paper is not yet included in his Google Scholar h-index and adding the citation for that paper brings his citation count to over 174,000 and his h-index to 211. Langer is recognized as the most cited engineer in history. Langer's research laboratory at MIT is the largest biomedical engineering lab in the world, maintaining over $10 million in annual grants and over 100 researchers. Langer is also currently on the board of directors at Bind Therapeutics and Ocata Therapeutics. In 2015, Langer was awarded the Queen Elizabeth Prize for Engineering, the most influential prize in the world for engineering.